Omega-3 fatty acids in food and pharma

The enabling role of biotechnology

Peter J. Gillies, William Harris, Penny M. Kris-Etherton

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Omega-3 fatty acid research, which began as an epidemiologic curiosity, has generated perhaps the strongest dataset for any nutrient in regard to cardiovascular disease risk reduction. Although once a relatively descriptive field, advances in analytic techniques have opened up the biochemistry of omega-3 fatty acids and nutritional genomics in plants and man and have taken the field into the "omic" era. Despite this progress, fundamental questions remain unanswered, such as which fatty acid or metabolite thereof drives a given health benefit, how much of a given fatty acid should we consume, and how do we best source the requisite fatty acids? Of these questions, the ability to source omega-3 fatty acids in order to meet dietary guidelines has become a practical concern. The advent of novel oils from plants and single cell organisms as enabled by biotechnology may provide a solution to this problem and in the process open up new uses for omega-3 fatty acids in dietary supplements and drugs.

Original languageEnglish (US)
Pages (from-to)467-473
Number of pages7
JournalCurrent Atherosclerosis Reports
Volume13
Issue number6
DOIs
StatePublished - Dec 2011
Externally publishedYes

Fingerprint

Omega-3 Fatty Acids
Biotechnology
Food
Fatty Acids
Nutrigenomics
Nutrition Policy
Exploratory Behavior
Aptitude
Plant Cells
Insurance Benefits
Risk Reduction Behavior
Dietary Supplements
Biochemistry
Oils
Cardiovascular Diseases
Research
Pharmaceutical Preparations

Keywords

  • Dietary guidelines
  • Dietary supplements, drugs
  • Docosahexaenoic acid
  • Eicosapentaenoic acid
  • LDL, small dense LDL
  • Lp-PLA
  • Omega-3 index
  • Resolvins
  • Single cell oils, soybean oil
  • Stearidonic acid

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Omega-3 fatty acids in food and pharma : The enabling role of biotechnology. / Gillies, Peter J.; Harris, William; Kris-Etherton, Penny M.

In: Current Atherosclerosis Reports, Vol. 13, No. 6, 12.2011, p. 467-473.

Research output: Contribution to journalArticle

Gillies, Peter J. ; Harris, William ; Kris-Etherton, Penny M. / Omega-3 fatty acids in food and pharma : The enabling role of biotechnology. In: Current Atherosclerosis Reports. 2011 ; Vol. 13, No. 6. pp. 467-473.
@article{37a243febe3745009b3cf4f447afe53d,
title = "Omega-3 fatty acids in food and pharma: The enabling role of biotechnology",
abstract = "Omega-3 fatty acid research, which began as an epidemiologic curiosity, has generated perhaps the strongest dataset for any nutrient in regard to cardiovascular disease risk reduction. Although once a relatively descriptive field, advances in analytic techniques have opened up the biochemistry of omega-3 fatty acids and nutritional genomics in plants and man and have taken the field into the {"}omic{"} era. Despite this progress, fundamental questions remain unanswered, such as which fatty acid or metabolite thereof drives a given health benefit, how much of a given fatty acid should we consume, and how do we best source the requisite fatty acids? Of these questions, the ability to source omega-3 fatty acids in order to meet dietary guidelines has become a practical concern. The advent of novel oils from plants and single cell organisms as enabled by biotechnology may provide a solution to this problem and in the process open up new uses for omega-3 fatty acids in dietary supplements and drugs.",
keywords = "Dietary guidelines, Dietary supplements, drugs, Docosahexaenoic acid, Eicosapentaenoic acid, LDL, small dense LDL, Lp-PLA, Omega-3 index, Resolvins, Single cell oils, soybean oil, Stearidonic acid",
author = "Gillies, {Peter J.} and William Harris and Kris-Etherton, {Penny M.}",
year = "2011",
month = "12",
doi = "10.1007/s11883-011-0206-z",
language = "English (US)",
volume = "13",
pages = "467--473",
journal = "Current Atherosclerosis Reports",
issn = "1523-3804",
publisher = "Current Medicine Group",
number = "6",

}

TY - JOUR

T1 - Omega-3 fatty acids in food and pharma

T2 - The enabling role of biotechnology

AU - Gillies, Peter J.

AU - Harris, William

AU - Kris-Etherton, Penny M.

PY - 2011/12

Y1 - 2011/12

N2 - Omega-3 fatty acid research, which began as an epidemiologic curiosity, has generated perhaps the strongest dataset for any nutrient in regard to cardiovascular disease risk reduction. Although once a relatively descriptive field, advances in analytic techniques have opened up the biochemistry of omega-3 fatty acids and nutritional genomics in plants and man and have taken the field into the "omic" era. Despite this progress, fundamental questions remain unanswered, such as which fatty acid or metabolite thereof drives a given health benefit, how much of a given fatty acid should we consume, and how do we best source the requisite fatty acids? Of these questions, the ability to source omega-3 fatty acids in order to meet dietary guidelines has become a practical concern. The advent of novel oils from plants and single cell organisms as enabled by biotechnology may provide a solution to this problem and in the process open up new uses for omega-3 fatty acids in dietary supplements and drugs.

AB - Omega-3 fatty acid research, which began as an epidemiologic curiosity, has generated perhaps the strongest dataset for any nutrient in regard to cardiovascular disease risk reduction. Although once a relatively descriptive field, advances in analytic techniques have opened up the biochemistry of omega-3 fatty acids and nutritional genomics in plants and man and have taken the field into the "omic" era. Despite this progress, fundamental questions remain unanswered, such as which fatty acid or metabolite thereof drives a given health benefit, how much of a given fatty acid should we consume, and how do we best source the requisite fatty acids? Of these questions, the ability to source omega-3 fatty acids in order to meet dietary guidelines has become a practical concern. The advent of novel oils from plants and single cell organisms as enabled by biotechnology may provide a solution to this problem and in the process open up new uses for omega-3 fatty acids in dietary supplements and drugs.

KW - Dietary guidelines

KW - Dietary supplements, drugs

KW - Docosahexaenoic acid

KW - Eicosapentaenoic acid

KW - LDL, small dense LDL

KW - Lp-PLA

KW - Omega-3 index

KW - Resolvins

KW - Single cell oils, soybean oil

KW - Stearidonic acid

UR - http://www.scopus.com/inward/record.url?scp=81155133750&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=81155133750&partnerID=8YFLogxK

U2 - 10.1007/s11883-011-0206-z

DO - 10.1007/s11883-011-0206-z

M3 - Article

VL - 13

SP - 467

EP - 473

JO - Current Atherosclerosis Reports

JF - Current Atherosclerosis Reports

SN - 1523-3804

IS - 6

ER -